A tender has been published for Indian Army TAB ANASTROZOLE 1 MG, TAB AZATHIOPRINE 100MG, TAB BICALUTAMIDE 50 MG, TAB EVEROLIMUS 0 point 5 MG, CAP NIFEDIPINE RETARD 20 MG, TAB TACROLIMUS 1 MG, TAB TAMOXIFEN CITRATE 20 MG, TAB TADALAFIL 20 MG, TAB ACENOCOUMAROL 1 MG, TAB DILTIAZEM 90 MG Controlled Delivery, TAB ACENOCOUMAROL 2MG, TAB INDAPAMIDE SR 1point 5 MG, TAB ISOSORBIDE DINITRATE 10 MG, TAB ISOSORBIDE 5 MONONITRATE 20 MG, TAB PERINDOPRIL 4 MG in HYDERABAD, TELANGANA. Quantity: 47560 by. Submission Deadline: 12-04-2025 09: 00: 00. Check eligibility and apply.
Government Tender Published for TAB ANASTROZOLE 1 MG,TAB AZATHIOPRINE 100MG,TAB BICALUTAMIDE 50 MG,TAB EVEROLIMUS 0 point 5 MG,CAP in HYDERABAD, TELANGANA
Progress
RAQuantity
47560
Categories
3
Bill of Quantities (BOQ)
15 Items
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | TAB ANASTROZOLE 1 MG | TAB | 1,000 | no | ms18473f | 30 |
| 2 | TAB AZATHIOPRINE 100MG | TAB | 300 | no | ms18473f | 30 |
| 3 | TAB BICALUTAMIDE 50 MG | TAB | 2,700 | no | ms18473f | 30 |
| 4 | TAB EVEROLIMUS 0 point 5 MG | TAB | 360 | no | ms18473f | 30 |
| 5 | CAP NIFEDIPINE RETARD 20 MG | TAB | 6,500 | no | ms18473f | 30 |
| 6 | TAB TACROLIMUS 1 MG | TAB | 600 | no | ms18473f | 30 |
| 7 | TAB TAMOXIFEN CITRATE 20 MG | TAB | 600 | no | ms18473f | 30 |
| 8 | TAB TADALAFIL 20 MG | TAB | 300 | no | ms18473f | 30 |
| 9 | TAB ACENOCOUMAROL 1 MG | TAB | 3,800 | no | ms18473f | 30 |
| 10 | TAB DILTIAZEM 90 MG Controlled Delivery | TAB | 7,800 | no | ms18473f | 30 |
| 11 | TAB ACENOCOUMAROL 2MG | TAB | 2,400 | no | ms18473f | 30 |
| 12 | TAB INDAPAMIDE SR 1point 5 MG | TAB | 5,700 | no | ms18473f | 30 |
| 13 | TAB ISOSORBIDE DINITRATE 10 MG | TAB | 5,600 | no | ms18473f | 30 |
| 14 | TAB ISOSORBIDE 5 MONONITRATE 20 MG | TAB | 7,800 | no | ms18473f | 30 |
| 15 | TAB PERINDOPRIL 4 MG | TAB | 2,100 | no | ms18473f | 30 |
AI-Powered Bidder Prediction
Companies most likely to bid
Unlock Bidder Insights
AI predictions on likely bidders
Reverse Auction Schedule
Start
25 Apr 2025, 07:00 pm
End
26 Apr 2025, 07:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Frequently Asked Questions
What are the eligibility requirements for **GEM/2025/B/6078870**?
The eligibility requirements include being a registered entity with necessary licenses to supply pharmaceuticals. Additionally, bidders should demonstrate prior experience in supplying similar products, especially to government or military organizations. Compliance with these conditions is critical to participate successfully in the tender.
What specific technical specifications must be adhered to in this tender?
Bidders need to adhere to strict technical specifications that demand compliance with national quality standards. Suppliers must ensure that all pharmaceuticals are produced in ISO certified facilities and that they can provide comprehensive evidence of quality assurance and testing processes that align with military health regulations.
What are the **payment terms** associated with this tender?
The payment terms for this tender will be outlined in the final contract agreement. Typically, payment may be processed upon delivery and successful inspection of the pharmaceuticals. Bidders should be prepared to adhere to government payment protocols outlined at the point of contract negotiation.
How are the submitted documents evaluated during the selection process?
The evaluation process is conducted in two phases: a technical evaluation which assesses compliance against the tender's requirements and a financial evaluation that examines pricing proposals and financial viability. Bidders are ranked based on a combined score from both evaluations, leading to the selection of the most suitable candidate.
What opportunities exist for **Micro, Small, and Medium Enterprises (MSEs)** within this tender?
This tender comes with special provisions to encourage participation from Micro, Small, and Medium Enterprises (MSEs), which can receive support and potentially favorable evaluation during the decision-making process. Embracing MSEs is part of a broader initiative to foster inclusivity in government procurement, thereby enabling diverse suppliers to contribute to military supply chains.
Download FREE!
Access all tender documents at no cost
Documents 4
GeM-Bidding-7670522.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
GeM-Bidding-7670522.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS